Literature DB >> 9422130

Mild head injury--a positive approach to management.

D W Hodgkinson1, E Berry, D W Yates.   

Abstract

It is estimated that 1.4 million patients each year attend Accident and Emergency (A&E) departments in the UK with a head injury. The vast majority are, in retrospect, diagnosed as a 'mild' injury. There is evidence to suggest that many develop short term morbidity and some long term problems. The incidence is unknown. Early recognition and treatment many hasten recovery. A national postal survey of A&E departments revealed a general unawareness for this morbidity. Written advice given to patients on discharge from the departments was exclusively concerned with the symptoms expected if serious complications developed. A description of the common symptoms of fatigue, poor memory and concentration were not given to the patients in a written format. Arrangements for follow up are, in the majority of hospitals, unstructured. We recommend a positive approach to the management and follow up of mild head injury. This should recognize the common problems experienced by these patients and cater for their needs. More interest and research is required into this aspect of head injury.

Entities:  

Mesh:

Year:  1994        PMID: 9422130     DOI: 10.1097/00063110-199403000-00003

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  3 in total

1.  Head injuries and the observation ward.

Authors:  A Jones; K O'Driscoll; L C Luke
Journal:  J Accid Emerg Med       Date:  1995-06

2.  Head injury outcome prediction in the emergency department: a role for protein S-100B?

Authors:  W J Townend; M J Guy; M A Pani; B Martin; D W Yates
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

3.  What's in a number? Problems with counting traumatic brain injuries.

Authors:  Benjamin Michael Bloom; Virginia Newcombe; Ian Roberts
Journal:  Emerg Med J       Date:  2021-11-23       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.